Heparin's role in biological processes is commonly mediated by its interaction with proteins [1] . During the past decade, our research group has relied on surface plasmon resonance (SPR) 1 to monitor heparin-protein interactions [2] [3] [4] [5] [6] [7] [8] . Heparin is typically immobilized on the chip, and protein Xows over the heparinized surface. Unfortunately, nonspeciWc interaction between analyte and the chip surface is frequently encountered. Although physical adsorption of the protein can be minimized using surfaces coated with hydrophilic polymers such as dextran, we have recently encountered a number of heparin-binding proteins that interact with dextran. Poly(ethylene glycol) (PEG)-based sensor chips might represent an alternative to the dextran-based sensor chips, for the study of heparin-protein interactions, because surfaces grafted with PEG typically show reduced protein adsorption [9] . In the current work, we describe the application of a PEG-based SPR sensor chip to acquire kinetic and aYnity data on the interaction of complement protein factor P with heparin, an interaction that could not be studied with commercially available sensor chips.
Gold (Au) and CM5 sensor chips, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS), ethanolamine-HCl, and HBS-EP buVer (0.01 M Hepes (pH 7.4), 0.15 M NaCl, 3 mM ethylenediamine tetraacetic acid (EDTA), 0.005% surfactant P20) were obtained from BIAcore (Uppsala, Sweden). Phosphate-buVered saline (PBS) consisted of a 50-mM sodium phosphate solution (pH 7.2) containing 100 mM NaCl. Sulfo-N-hydroxysuccinimide-long chainbiotin (sulfo-NHS-LC-biotin) and neutravidin were obtained from Pierce (Rockford, IL, USA). Porcine intestinal heparin (sodium salt) and 3,3Ј-dithio-bis(propionic acid N-hydroxysuccinimide ester) (DTSP-NHS) were obtained from Sigma (St. Louis, MO, USA). mPEG-SH (5000 MW) and HCl·H 2 N-PEG-COOH (5000 MW) were obtained from Nektar (Huntsville, AL, USA). Double distilled water and CH 2 Cl 2 (HPLC grade) were used. All buVers were Wltered (0.22 m) and degassed prior to using. SPR experiments were performed on a BIAcore 3000 instrument with BIAcore 3000 control and BIAevaluation software (version 4.0.1).
A solution of DTSP-NHS in CH 2 Cl 2 (1.2 mg in 4 ml, 0.75 mM) was added to a solution of HCl·H 2 N-PEG-COOH in CH 2 Cl 2 (15 mg in 1 ml, 3 mM). The mixture was incubated for 12 h at 4°C. The solvent was evaporated in vacuo, and the residual solid was redissolved with a minimal amount of H 2 O, Wltered (0.22 m), dialyzed (3500 MW cutoV), and lyophilized.
An mPEG-coated sensor chip was prepared by incubating the Au sensor chip with a solution of mPEG-SH (2 mg/ml in H 2 O) for 24 h at 4°C. After incubation, the chip was rinsed exhaustively with H 2 O.
A chip with a PEG-COOH matrix was prepared by incubating the Au sensor chip with a solution of -(SCH 2 CH 2 CONH-PEG-COOH) 2 (6 mg/ml in H 2 O) for 24 h at 4°C. The chip was then rinsed exhaustively with H 2 O. The surface immobilized with PEG-COOH was activated by incubating the PEG-COOH sensor chip for 30 min at 4°C with an equimolar mixture of NHS/EDC (Wnal concentration 0.05 M, mixed immediately prior to using). The chip was rinsed with 50 mM sodium acetate buVer (pH 4.0) and then incubated for 24 h at 4°C with a solution of neutravidin (2 mg/ml in sodium acetate buVer, pH 4.0). The chip was rinsed exhaustively with water, and the surface was incubated with ethanolamine (1.0 M) for 2 h at 4°C, to deactivate carboxyl groups that had not reacted with neutravidin.
Heparin-biotin conjugate was prepared by reaction of sulfo-NHS-LC-biotin with the free amino groups of unsubstituted glucosamine residues in heparin [10] . A solution of heparin-biotin conjugate (1 mg/ml in HBS-EP buVer) was passed over Xow cell 2 of the neutravidin-PEG sensor chip (Xow rate D 5 l/min, T D 25°C, running buVer: HBS-EP). The binding of heparin-biotin was conWrmed by the observation of a 100-RU response.
A solution of factor P (50 nM) in PBS or HBS-EP buVer was passed over the Au, CM-5, or mPEG sensor chip at Xow rate of 5 l/min (T D 25°C, running buVer: PBS or HBS-EP). A kinetic injection mode was used, leading the protein to Xow for 3 min over each chip and to be dissociated for the next 3 min.
Flow cell 2 of the neutravidin-PEG sensor chip, with heparin-biotin attached to the surface, was used for the kinetic binding measurement. Flow cell 1, consisting of only neutravidin-PEG, was used as a control. DiVerent concentrations of factor P (60, 50, 40, and 35 nM) in HBS-EP buVer were injected at a Xow rate of 30 l/min (T D 25°C, running buVer: HBS-EP) over Xow cells 1 and 2. A kinetic injection mode was used, leading the protein to Xow for 3 min and to be dissociated for the next 3 min. The surface was regenerated by the injection of 15 l (30 s) of SDS (0.5%), followed by two 30-l injections (60 s) of 2 M NaCl.
Two diVerent PEG-based sensor chips were prepared. The mPEG chip, having a -S-PEG derivative but no functional group available at the end of the polymer chain, was used to determine the ability of PEG to prevent nonspeciWc protein binding. The PEG-COOH chip, consisting of a PEG derivative with an available carboxyl group, was used to prepare a neutravidin-PEG chip. Neutravidin, a biotin binding protein, was covalently attached to the PEG-COOH sensor chip by amide formation between the carboxyl groups of the PEG and the amino groups of the protein. Biotinylated heparin was then bound to prepare a heparin chip.
Factor P, also called properdin, functions as an enhancing regulator in the complement alternative pathway and is believed to bind to heparin [11, 12] . Previous eVorts to study heparin-factor P interaction using a streptavidin-dextran matrix-based sensor chip failed due to nonspeciWc interaction of factor P with the chip surface. The nonspeciWc binding of factor P was compared on an mPEG chip, an untreated gold surface (Au sensor chip), and a gold surface containing a dextran matrix (CM5 sensor chip). A solution of factor P (50 nM) in PBS was injected over all three surfaces under identical experiment conditions. The binding process on the mPEG chip gave a much lower response (315 RU) compared with RU changes from CM5 and Au chips of 2525 and 610 RU, respectively (Fig. 1A) . When the experiment was repeated using HBS-EP buVer containing surfactant, the nonspeciWc binding of factor P with the gold surface and the dextran matrix was reduced (184 and 254 RU, respectively), and no detectable interaction was observed between factor P and PEG (Fig. 1B) . By switching to PEG matrix, we removed 88% (in PBS buVer) and 100% (in HBS-EP buVer) of the nonspeciWc binding observed with the dextran. These results clearly demonstrate that nonspeciWc binding of factor P can be eliminated using a PEG-based chip.
The interaction of factor P with heparin was studied using a neutravidin-PEG chip with immobilized heparin. At 25°C, diVerent concentrations (60, 50, 40, and 35 nM) of factor P in HBS-EP buVer were injected over the chip at a Xow rate of 30 l/min (running buVer: HBS-EP). The nonspeciWc binding of factor P protein to the material other than heparin (probably neutravidin) was less than 20% of the total response obtained. The binding curves under diVerent concentrations were globally, and then individually, Wtted with a 1:1 Langmuir binding model with mass transport limitation (Fig. 1C) . The Wttings showed similar kinetic and aYnity data, with 2 values less than 3.22 (Table 1 ). The SPR data showed that factor P binds heparin quite strongly, with a K D of 1.09 nM (global Wtting).
We have demonstrated that PEG-based biosensor chips oVer an alternative to dextran-based chips when an analyte interacts nonspeciWcally with a dextran matrix. PEG-based chips are easy to prepare and aVord high baseline stability. We repeatably obtained excellent binding sensorgrams for the interaction between factor P and heparin using these chips. Other heparin-binding proteins examined in our laboratory have also exhibited signiWcant nonspeciWc interactions with dextran matrix. Thus, we have replaced standard commercial chips with new PEG-based sensor chips to measure interactions between these proteins and heparin. 
